138 related articles for article (PubMed ID: 35029263)
1. Prostate-specific membrane antigen (PSMA) targeted singlet oxygen delivery
Wang L; Tang L; Liu Y; Wu H; Liu Z; Li J; Pan Y; Akkaya EU
Chem Commun (Camb); 2022 Feb; 58(12):1902-1905. PubMed ID: 35029263
[TBL] [Abstract][Full Text] [Related]
2. Long-Circulating Prostate-Specific Membrane Antigen-Targeted NIR Phototheranostic Agent.
Overchuk M; Damen MPF; Harmatys KM; Pomper MG; Chen J; Zheng G
Photochem Photobiol; 2020 May; 96(3):718-724. PubMed ID: 31742696
[TBL] [Abstract][Full Text] [Related]
3. Prostate-specific membrane antigen (PSMA)-targeted photodynamic therapy enhances the delivery of PSMA-targeted magnetic nanoparticles to PSMA-expressing prostate tumors.
Ngen EJ; Chen Y; Azad BB; Boinapally S; Jacob D; Lisok A; Shen C; Hossain MS; Jin J; Bhujwalla ZM; Pomper MG; Banerjee SR
Nanotheranostics; 2021; 5(2):182-196. PubMed ID: 33564617
[TBL] [Abstract][Full Text] [Related]
4. Theranostic PSMA ligands with optimized backbones for intraoperative multimodal imaging and photodynamic therapy of prostate cancer.
Derks YHW; van Lith SAM; Amatdjais-Groenen HIV; Wouters LWM; Kip A; Franssen GM; Laverman P; Löwik DWPM; Heskamp S; Rijpkema M
Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2425-2435. PubMed ID: 35029739
[TBL] [Abstract][Full Text] [Related]
5. Epidermal Growth Factor Receptor-Targeted Delivery of a Singlet-Oxygen Sensitizer with Thermal Controlled Release for Efficient Anticancer Therapy.
Chen J; Li D; Huo B; Zhang F; Zhao X; Yuan G; Chen D; Song M; Xue J
Mol Pharm; 2019 Aug; 16(8):3703-3710. PubMed ID: 31276423
[TBL] [Abstract][Full Text] [Related]
6. Theranostic Agents for Photodynamic Therapy of Prostate Cancer by Targeting Prostate-Specific Membrane Antigen.
Wang X; Tsui B; Ramamurthy G; Zhang P; Meyers J; Kenney ME; Kiechle J; Ponsky L; Basilion JP
Mol Cancer Ther; 2016 Aug; 15(8):1834-44. PubMed ID: 27297866
[TBL] [Abstract][Full Text] [Related]
7. A Bifunctional Photosensitizer for Enhanced Fractional Photodynamic Therapy: Singlet Oxygen Generation in the Presence and Absence of Light.
Turan IS; Yildiz D; Turksoy A; Gunaydin G; Akkaya EU
Angew Chem Int Ed Engl; 2016 Feb; 55(8):2875-8. PubMed ID: 26799149
[TBL] [Abstract][Full Text] [Related]
8. Comparison of low-molecular-weight ligand and whole antibody in prostate-specific membrane antigen targeted near-infrared photoimmunotherapy.
Nakajima K; Miyazaki F; Terada K; Takakura H; Suzuki M; Ogawa M
Int J Pharm; 2021 Nov; 609():121135. PubMed ID: 34571072
[TBL] [Abstract][Full Text] [Related]
9. Targeted therapies for prostate cancer against the prostate specific membrane antigen.
Elsässer-Beile U; Bühler P; Wolf P
Curr Drug Targets; 2009 Feb; 10(2):118-25. PubMed ID: 19199907
[TBL] [Abstract][Full Text] [Related]
10. A PSMA-targeted theranostic agent for photodynamic therapy.
Chen Y; Chatterjee S; Lisok A; Minn I; Pullambhatla M; Wharram B; Wang Y; Jin J; Bhujwalla ZM; Nimmagadda S; Mease RC; Pomper MG
J Photochem Photobiol B; 2017 Feb; 167():111-116. PubMed ID: 28063300
[TBL] [Abstract][Full Text] [Related]
11. Antibody-drug conjugates targeting prostate-specific membrane antigen.
Olson WC; Israel RJ
Front Biosci (Landmark Ed); 2014 Jan; 19(1):12-33. PubMed ID: 24389170
[TBL] [Abstract][Full Text] [Related]
12. Efficacy Against Human Prostate Cancer by Prostate-specific Membrane Antigen-specific, Transforming Growth Factor-β Insensitive Genetically Targeted CD8
Zhang Q; Helfand BT; Carneiro BA; Qin W; Yang XJ; Lee C; Zhang W; Giles FJ; Cristofanilli M; Kuzel TM
Eur Urol; 2018 May; 73(5):648-652. PubMed ID: 29275833
[TBL] [Abstract][Full Text] [Related]
13. Proof-of-principle for two-stage photodynamic therapy: hypoxia triggered release of singlet oxygen.
Ayan S; Gunaydin G; Yesilgul-Mehmetcik N; Gedik ME; Seven O; Akkaya EU
Chem Commun (Camb); 2020 Nov; 56(94):14793-14796. PubMed ID: 33196713
[TBL] [Abstract][Full Text] [Related]
14. Discovery of PSMA-specific peptide ligands for targeted drug delivery.
Jin W; Qin B; Chen Z; Liu H; Barve A; Cheng K
Int J Pharm; 2016 Nov; 513(1-2):138-147. PubMed ID: 27582001
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic Therapy Is an Effective Adjuvant Therapy for Image-Guided Surgery in Prostate Cancer.
Wang X; Ramamurthy G; Shirke AA; Walker E; Mangadlao J; Wang Z; Wang Y; Shan L; Schluchter MD; Dong Z; Brady-Kalnay SM; Walker NK; Gargesha M; MacLennan G; Luo D; Sun R; Scott B; Roy D; Li J; Basilion JP
Cancer Res; 2020 Jan; 80(2):156-162. PubMed ID: 31719100
[TBL] [Abstract][Full Text] [Related]
16. Calculation of singlet oxygen dose from photosensitizer fluorescence and photobleaching during mTHPC photodynamic therapy of MLL cells.
Dysart JS; Singh G; Patterson MS
Photochem Photobiol; 2005; 81(1):196-205. PubMed ID: 15469385
[TBL] [Abstract][Full Text] [Related]
17. Targeted photodynamic therapy for prostate cancer: inducing apoptosis via activation of the caspase-8/-3 cascade pathway.
Liu T; Wu LY; Choi JK; Berkman CE
Int J Oncol; 2010 Apr; 36(4):777-84. PubMed ID: 20198319
[TBL] [Abstract][Full Text] [Related]
18. Oxygen-independent combined photothermal/photodynamic therapy delivered by tumor acidity-responsive polymeric micelles.
Han Y; Chen Z; Zhao H; Zha Z; Ke W; Wang Y; Ge Z
J Control Release; 2018 Aug; 284():15-25. PubMed ID: 29894709
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors.
Lütje S; Heskamp S; Franssen GM; Frielink C; Kip A; Hekman M; Fracasso G; Colombatti M; Herrmann K; Boerman OC; Gotthardt M; Rijpkema M
Theranostics; 2019; 9(10):2924-2938. PubMed ID: 31244933
[No Abstract] [Full Text] [Related]
20. Remote-Controlled Release of Singlet Oxygen by the Plasmonic Heating of Endoperoxide-Modified Gold Nanorods: Towards a Paradigm Change in Photodynamic Therapy.
Kolemen S; Ozdemir T; Lee D; Kim GM; Karatas T; Yoon J; Akkaya EU
Angew Chem Int Ed Engl; 2016 Mar; 55(11):3606-10. PubMed ID: 26845734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
